Physician profile
Brian Blumenauer
NPI 1184041386
$2,436.07
in general payments reported to CMS, 2019-2025
10 companies · $584 in 2025
The $584 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $238 · 2023: $442 · 2024: $1,171 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661 · Long Term Medical Supply Or Device Loan: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.02 |
| Long Term Medical Supply Or Device Loan | $537.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $803.59 | 2024-2025 | Daxi, Daxxify |
| Integra Lifesciences Corporation | $601.87 | 2024-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Mentor Worldwide LLC | $418.22 | 2022-2023 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $325.59 | 2024-2025 | |
| Allergan, INC. | $169.18 | 2022 | |
| Davol INC. | $30.60 | 2023 | Phasix Mesh |
| Boston Scientific Corporation | $24.60 | 2025 | Watchman Flx |
| Musculoskeletal Transplant Foundation INC. | $22.14 | 2022 | |
| Galderma Laboratories, L.P. | $21.28 | 2023 | |
| Acorda Therapeutics, INC | $19.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Blumenauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.